Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.5250 (4.99%) ($8.5250 - $8.5250) on Mon. Dec. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.32% (three month average) | RSI | 88 | Latest Price | $8.5250(4.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 29.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.66% in a week (0% probabilities). VIXM(-18%) UUP(-13%) VXX(-8%) TBT(-3%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.66% (StdDev 5.32%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.83(8.88%) | 10 Day Moving Average | $6.83(24.82%) | 20 Day Moving Average | $5.75(48.26%) | To recent high | 0% | To recent low | 69.3% | Market Cap | $1.504b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |